Clinical trial
The Multiple Sclerosis Self Monitoring Study: An Intervention Study on the Effect of Digital Self-monitoring-based Management of Relapsing and Remitting Multiple Sclerosis on Self-efficacy, Clinical Outcomes and Cost-effectiveness
NCT06125301 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Multiple Sclerosis Self Monitoring Study: An Intervention Study on the Effect of Digital Self-monitoring-based Management of Relapsing and Remitting Multiple Sclerosis on Self-efficacy, Clinical Outcomes and Cost-effectiveness
- Lead sponsor
- Amsterdam UMC, location VUmc
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 15, 2022
- Completion date
- August 15, 2024
- Enrollment
- 225 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.